Sorafenib Tosylate

Name: Sorafenib Tosylate
Brand: 济南圣和化工有限公司

CAS 475207-59-1C28H24ClF3N4O6SMW 637.0

Sorafenib Tosylate，CAS 登记号 475207-59-1，由济南圣和化工有限公司现货供应，可提供纯度按批次COA提供(不公开发布) 的规格，下游主要用于Organic Chemicals。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。

规格参数

CAS号475207-59-1

分子式C28H24ClF3N4O6S

分子量637.0

纯度按批次COA提供(不公开发布)

包装按订单/批次确认(不公开发布)

应用领域Organic Chemicals

类别Organic Chemicals

用途与场景

Organic Chemicals

包装与供货

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

供货周期现货/按订单安排

文件与支持

每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。

常见问题

在哪里能查到 Sorafenib Tosylate 的 CAS 号？

本页已列出 Sorafenib Tosylate 的 CAS 号：475207-59-1，可与随货 COA 核对。

可以提供哪些规格和包装？

常见纯度为按批次COA提供(不公开发布)，包装形式为按订单/批次确认(不公开发布)，特殊规格可在询价时说明。

Sorafenib Tosylate 一般用在什么产品里？

主要涉及Organic Chemicals。

下单流程是怎样的？

来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。

PubChem 公开数据

Description

Sorafenib Tosylate · CAS 475207-59-1 · C28H24ClF3N4O6S. UNII 5T62Q3B36J.

Identification

CAS Registry Number	475207-59-1
PubChem CID	406563
Molecular formula	C28H24ClF3N4O6S
IUPAC name	4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
UNII (FDA)	5T62Q3B36J

Computed Descriptors

Molecular Weight	637.0
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	6
Exact Mass	636.1057179
Monoisotopic Mass	636.1057179
Topological Polar Surface Area	155
Heavy Atom Count	43
Formal Charge	0
Complexity	853

GHS Hazard Classification

Reported hazard statements	H302 (31%), H332 (28.6%), H360 (73.8%), H373 (64.3%), H412 (21.4%)

H302 (31%): Harmful if swallowed [Warning Acute toxicity, oral]

H332 (28.6%): Harmful if inhaled [Warning Acute toxicity, inhalation]

Documented Uses

Sorafenib is indicated for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinoma.
Breast Feeding; Lactation; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Tyrosine Kinase Inhibitors;
Sorafenib tosylate is approved to treat:
• Hepatocellular carcinoma (a type of liver cancer) that cannot be removed by surgery.
• Renal cell carcinoma (a type of kidney cancer) that is advanced.
• Thyroid cancer in certain patients whose cancer has gotten worse, has come back, or has spread to other parts of the body and did not respond to treatment with radioactive iodine.

Synonyms

Sorafenib tosylate; 475207-59-1; Nexavar; Sorafenib tosilate; DTXSID9047839; BAY 54-9085; 5T62Q3B36J; NSC724772; BAY-54-9085; BAY 43-9006 tosylate; DTXCID9027817; CHEBI:50928; RefChem:57444; 641-758-8; Sorafenib tosylate [USAN]; MFCD08235032

Frequently Asked Questions

What are the CAS number and molecular formula of Sorafenib Tosylate?

CAS 475207-59-1; molecular formula C28H24ClF3N4O6S; molecular weight — g/mol.

What other names is Sorafenib Tosylate known by?

Sorafenib tosylate, 475207-59-1, Nexavar, Sorafenib tosilate, DTXSID9047839, BAY 54-9085.

Is Sorafenib Tosylate classified as hazardous?

Hazard statements reported: H302, H332, H360, H373, H412.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

获取 Sorafenib Tosylate 报价

供应商：济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp